1.
A A Pract
; 16(8): e01604, 2022 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35917204
RESUMO
The use of mechanical circulatory support (MCS) devices continues to expand in cases of refractory cardiogenic shock. Bleeding is one of the most common complications associated with MCS, and management can be challenging due to need for systemic anticoagulation. Significant hemoptysis can be a devastating complication. We describe a case of a patient supported by a right ventricular assist device with an oxygenator and a left ventricular assist device who developed pulmonary hemorrhage that was successfully treated with nebulized tranexamic acid (TXA). Following a 5-day treatment course, bleeding resolved, no adverse side effects were noted, and systemic anticoagulation was resumed.
Assuntos
Coração Auxiliar , Ácido Tranexâmico , Anticoagulantes , Coração Auxiliar/efeitos adversos , Hemoptise/complicações , Hemoptise/tratamento farmacológico , Hemorragia/complicações , Humanos , Choque Cardiogênico/tratamento farmacológico , Choque Cardiogênico/etiologia , Ácido Tranexâmico/uso terapêutico
2.
BMJ Case Rep
; 20172017 Oct 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29038195